Home Interviews Ultimovacs CEO: “Data could put us at the forefront of cancer vaccine...

Interviews
News
Nyheter
Studio

Ultimovacs CEO: “Data could put us at the forefront of cancer vaccine field”

24 November, 2023

Ultimovacs CEO: “Data could put us at the forefront of cancer vaccine field”

24 November, 2023

Ultimovacs has announced positive survival data from the phase II NIPU trial assessing the universal cancer vaccine UV1 in malignant mesothelioma. The company’s CEO Carlos de Sousa talked to BioStock about the results and what they mean for the oncology field.

Watch the interview with Ultimovacs‘ CEO Carlos de Sousa below.

The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.